企業プロフィール
Jazz Pharmaceuticals 株価・ニュース・カタリスト
- ティッカー:
- JAZZ
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- Ireland
株価パフォーマンス
248.36 USD (+1.39%)
終値
最終更新: 2026年8月17日
14.2B USD
時価総額
株価変動の要因
As of Aug 17, 2026, JAZZ closed up 1.39% at $248.36. No new same-company headline was identified in the current news window.
企業概要
事業概要
Jazz Pharmaceuticals is a biopharmaceutical company focused on neuroscience, oncology, and sleep disorder therapies. Its portfolio mixes established commercial products with development programs aimed at extending the company’s specialty franchise.
所在地とセクター分類
Headquartered in Ireland and listed on NASDAQ, Jazz has a global commercial footprint and a specialty-pharma identity. It sits in neuroscience and oncology rather than broad pharma.
ビジネスモデルの特徴
The company generates value through specialty product sales, lifecycle management, and pipeline development in difficult-to-treat diseases. Investors watch revenue durability, patent and label risk, and the progress of new assets.
バイオ業界での位置付け
Jazz occupies a steady specialty-biopharma position with catalyst sensitivity around pipeline and label updates. It is more commercial than a pure development-stage biotech name but still reacts to program milestones.
今後のカタリスト
- Jazz Pharmaceuticals’ catalysts are Xywav and oncology franchise execution, plus any pipeline update that extends the sleep-and-cancer mix. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。